APA (7th ed.) Citation

Chua, L., Otani, Y., Lin, Z., Friedrich, S., Durand, F., & Zhang, X. C. Mirikizumab Pharmacokinetics and Exposure‐Response in Patients With Moderately‐To‐Severely Active Crohn's Disease: Results From Two Randomized Studies. Wiley.

Chicago Style (17th ed.) Citation

Chua, Laiyi, Yuki Otani, Zhantao Lin, Stuart Friedrich, Frederick Durand, and Xin Cindy Zhang. Mirikizumab Pharmacokinetics and Exposure‐Response in Patients With Moderately‐To‐Severely Active Crohn's Disease: Results From Two Randomized Studies. Wiley.

MLA (9th ed.) Citation

Chua, Laiyi, et al. Mirikizumab Pharmacokinetics and Exposure‐Response in Patients With Moderately‐To‐Severely Active Crohn's Disease: Results From Two Randomized Studies. Wiley.